Effects of storage duration and volume on the quality of leukoreduced apheresis-derived platelets: implications for pediatric transfusion medicine.
BACKGROUND
Platelet (PLT) storage adversely affects PLT structure and function in vitro and is associated with decreased PLT recovery and function in vivo. In pediatric transfusion medicine, it is not uncommon for small residual volumes to remain in parent units after aliquot preparation of leukoreduced apheresis-derived PLTs (LR-ADP). However, limited data exist regarding the impact of storage on residual small-volume LR-ADP.


METHODS
Standard metabolic testing was performed on residual volumes of LR-ADP after aliquot removal and PLT aggregometry using a dual agonist of ADP and collagen was performed on stored, small-volume aliquots (10-80mL) created from an in vitro model of PLT storage.


RESULTS
Seventy-seven LR-ADP underwent metabolic (n=67) or metabolic and aggregation (n=10) studies. All products maintained a pH value of more than 6.89 throughout storage. Lactate and pCO(2) increased proportionally with longer storage time. Regardless of acceptable metabolism during storage, aggregation in 10- to 20-mL aliquots was impaired by Day 4 and aliquots less than 40 mL demonstrated the most dramatic decrease in aggregation from baseline.


CONCLUSIONS
Despite maintenance of acceptable metabolic conditions, residual volumes of LR-ADP develop impaired aggregation in vitro that may adversely affect PLT survival and function in vivo. At volumes below 40mL, LR-ADP revealed reduced aggregation. As a result, it is recommended to monitor and record volumes of LR-ADP used for pediatric transfusion. Moreover, once LR-ADP attain a volume of 50mL or less on Day 4 or Day 5 of storage, consider discarding these products until their in vivo efficacy can be studied.
Winkler
Anne M
AM
Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA.
Sheppard
Chelsea A
CA
Culler
Elizabeth E
EE
Myers
Robert L
RL
Duncan
Alexander
A
Castillejo
Marta-Inés
MI
Hillyer
Christopher D
CD
Josephson
Cassandra D
CD
D001792:Blood Platelets / Q000166:cytology* / Q000378:metabolism*; D001793:Blood Preservation / Q000379:methods*; D002648:Child; D006801:Humans; D017713:Platelet Transfusion / Q000379:methods*; D010983:Plateletpheresis / Q000379:methods*; D013997:Time Factors
Transfus Apher Sci. 2007 Jun;36(3):285-9
17602871
Transfusion. 1994 May;34(5):407-11
8191565
Transfusion. 2006 Aug;46(8):1300-5
16934063
Transfusion. 2003 Feb;43(2):143-50
12559008
Transfus Apher Sci. 2002 Feb;26(1):29-34
11931375
Transfusion. 2000 Oct;40(10):1257-63
11061865
Transfusion. 2006 May;46(5):757-65
16686843
Anesth Analg. 2005 Jan;100(1):78-81
15616055
Blood. 1982 Mar;59(3):563-8
6800418
Transfusion. 2002 Jul;42(7):847-54
12375656
Transfusion. 2004 Jun;44(6):891-9
15157257
Transfusion. 2007 Apr;47(4):653-65
17381624
Transfusion. 1991 Jun;31(5):404-8
2048179
Transfusion. 2003 Sep;43(9):1230-7
12919425
Blood. 2005 Oct 15;106(8):2723-9
15972447
Transfusion. 2005 Feb;45(2):223-7
15660831
Transfus Med. 2003 Aug;13(4):173-87
12880388
Transfus Med. 2002 Oct;12(5):317-24
12383338
Transfus Med Rev. 1997 Apr;11(2):130-44
9140172